Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Tch Vct Regulatory News (AATG)

Share Price Information for Albion. Tch Vct (AATG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 67.50
Ask: 70.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.444%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
AATG Live PriceLast checked at -
Albion Technology & General VCT is an Investment Trust

To provide investors with a regular dividend income, combined with the prospect of long-term capital growth, through a balanced portfolio of unquoted growth and technology businesses in a qualifying VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Technology & General VCT PLC: Interim Management Statement

29 Nov 2023 15:10

Albion Technology & General VCT PLC: Interim Management Statement

Albion Technology & General VCT PLC Interim Management StatementLEI code: 213800TKJUY376H3KN16

IntroductionI present Albion Technology & General VCT PLC’s (the “Company”) interim management statement for the period from 1 July 2023 to 30 September 2023.

Performance and dividendsThe Company’s unaudited net asset value (NAV) on 30 September 2023 was £133.4 million or 75.05 pence per share (excluding treasury shares), a decrease of 0.97 pence per share (1.28%) since 30 June 2023.

A second dividend for the year ending 31 December 2023 of 1.90 pence per Ordinary share is to be paid on 29 December 2023 to shareholders on the register on 8 December 2023, resulting in total dividends of 3.72 pence per share for the year, a 5.1% yield on opening NAV.

FundraisingThe Company announced on 12 October 2023 that, subject to obtaining the requisite regulatory approval, it intended to launch a prospectus top up offer of new ordinary shares. Full details of the Offer will be contained in a prospectus that is expected to be published prior to launch in early January 2024.

PortfolioThe following investments have been made during the period from 1 July 2023 to 30 September 2023:

New investments£’000Activity
Phasecraft514Software for Quantum Computers
Kennek Solutions210Vertical software for lenders
Total new investments724 

Further investments£’000Activity
Gravitee637API management platform
uMedeor (T/A) uMed387A middleware technology platform that enables life science organisations to conduct medical research programmes
Accelex87Data extraction and analytics technology for private capital markets
Total further investments1,111 

Top ten holdings as at 30 September 2023:

InvestmentCarrying value£’000% of net asset valueActivity
Quantexa28,34121.2Network analytics platform to detect financial crime
Radnor House School (TopCo)6,1694.6Independent school for children aged 2-18
Proveca5,6564.2Reformulation of medicines for children
Oviva4,5813.4A technology enabled service business in medical nutritional therapy (MNT)
Chonais River Hydro3,8812.9Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
Cantab Research (T/A Speechmatics)3,4112.6Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device
Egress Software Technologies2,9152.2Encrypted email & file transfer service provider
The Evewell Group2,8922.2Operator and developer of women’s health centres focusing on fertility
Runa Network2,8292.1Cloud platform and infrastructure that enables corporates to issue digital incentives and payouts
Gharagain River Hydro2,3491.8Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands

Share buy-backsDuring the period from 1 July 2023 to 30 September 2023, the Company did not buy any shares.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for such buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.

Board compositionFollowing changes to the Board earlier this year, Peter Moorhouse has been appointed chairman of the Remuneration Committee from 29 November 2023.

Material events and transactions after the period end

As announced on 6 October 2023, the Company sold a proportion of its holding in Quantexa at its current holding value returning proceeds of £3.4m; andAs announced on 30 October 2023, following a formal tender process, Johnston Carmichael LLP were appointed as the Company's Auditor.

There have been no other material events or transactions after the period end to the date of this announcement.

Further informationFurther information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AATG.

Clive Richardson, Chairman29 November 2023

For further information please contact:Vikash HansraniOperations PartnerAlbion Capital Group LLPTelephone: 020 7601 1850

Date   Source Headline
18th Apr 20083:35 pmRNSFinal Results
31st Mar 20084:55 pmRNSTotal Voting Rights
29th Feb 20085:05 pmRNSTotal Voting Rights
31st Jan 20084:38 pmRNSTotal Voting Rights
2nd Jan 20085:13 pmRNSTotal Voting Rights
17th Dec 20075:36 pmRNSTransaction in Own Shares
10th Dec 20073:50 pmRNSNet Asset Value(s)
30th Nov 20074:41 pmRNSTotal Voting Rights
31st Oct 20074:06 pmRNSTotal Voting Rights
12th Oct 20072:24 pmRNSFSA document viewing facility
1st Oct 200711:58 amRNSTotal Voting Rights
26th Sep 20075:43 pmRNSInterim Results
3rd Sep 20075:28 pmRNSTotal Voting Rights
1st Aug 20073:21 pmRNSTotal Voting Rights
2nd Jul 200712:44 pmRNSTotal Voting Rights
15th Jun 200712:01 pmRNSTransaction in Own Shares
15th Jun 200711:23 amRNSNet Asset Value(s)
12th Jun 200711:26 amRNSDirector/PDMR Shareholding
1st Jun 20079:29 amRNSTotal Voting Rights
18th May 20072:35 pmRNSDoc re Annual Report
18th May 20072:24 pmRNSAnnual Information Update
11th May 20075:10 pmRNSTransaction in Own Shares
1st May 20073:17 pmRNSVoting rights and capital
20th Apr 20076:27 pmRNSFinal Results
2nd Apr 20079:34 amRNSVoting Rights and Capital
1st Feb 20074:01 pmRNSVoting rights and capital
22nd Dec 20061:00 pmRNSVoting Rights & Capital
21st Dec 20061:56 pmRNSNet Asset Value(s)
16th Oct 20063:27 pmRNSFSA Document Viewing Facility
27th Sep 20062:22 pmRNSTransaction in Own Shares
26th Sep 20063:34 pmRNSInterim Results
13th Sep 200612:25 pmRNSDirector Declaration
20th Jun 20063:36 pmRNSAnnual Information Update
16th Jun 20064:15 pmRNSTransaction in Own Shares
6th Jun 20063:53 pmRNSTransaction in Own Shares
26th May 20064:26 pmRNSTransaction in Own Shares
15th May 20063:48 pmRNSDirector/PDMR Shareholding
15th May 20063:41 pmRNSTransaction in Own Shares
11th May 20064:21 pmRNSDoc re. Rep & Fin statements
8th May 20062:54 pmRNSNet Asset Value(s)
26th Apr 20064:34 pmRNSDirector/PDMR Shareholding
13th Apr 20063:00 pmRNSFinal Results
5th Apr 200612:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20062:22 pmRNSIssue of Equity
31st Mar 20062:55 pmRNSIssue of Equity
24th Mar 20061:36 pmRNSOffer for subscription
3rd Mar 20063:29 pmRNSIssue of Equity
9th Feb 200610:01 amRNSDirector/PDMR Shareholding
3rd Feb 20064:25 pmRNSIssue of Equity
3rd Jan 20062:54 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.